# 68Ga-DOTA-TATE PET/CT Imaging in NETs

> **NCT04847505** · PHASE3 · RECRUITING · sponsor: **Centre de recherche du Centre hospitalier universitaire de Sherbrooke** · enrollment: 5000 (estimated)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-DOTA-TATE

## Key facts

- **NCT ID:** NCT04847505
- **Lead sponsor:** Centre de recherche du Centre hospitalier universitaire de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2024-07-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04847505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04847505, "68Ga-DOTA-TATE PET/CT Imaging in NETs". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04847505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*